Austrian medtech startup Flinn receives €1.8M in a pre-seed round
Summary
Vienna-based medical device compliance startup Flinn has received 1.8 million in a pre-seed round to automate work processes in medtech and the pharmaceutical industry. Launched in 2022 by ex-employees from German neobank N26 Bastian Krapinger-Ruther, Markus Muller, and Hasib Samad Flinn develops a SaaS platform that simplify quality management for regulatory matters through automation for a variety of repetitive form filling workflows. It will help to reduce complexity and cost incurred by the new EUs compliance framework Medical Device Regulation. To date, the startup plans to follow up with further software tools to create a modular and integration friendly medical compliance platform.We are here to stay and wont leave this industry before we havent enabled the major share of medical device manufacturers to automate large parts of todays manual tasks and build high-quality product significantly more efficient, The fresh round was co-led by Austrian Speedinvest, one of the Europes most active seed investors, that recently raised 500 million to invest in early-stage tech startups, and Berlin-headquartered VC firm that invests in early-stage B2B software companies focusing on deeptech, SaaS, security, IoT. Flinn is planning to use the fresh funding to digitize and bring automation to paper compliance trails linked to a recent EU rule change.